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Edited by Sandro SonninoAbstract The ATP-binding cassette transporter ABCG1 medi-
ates the transport of excess cholesterol from macrophages and
other cell types to high density lipoprotein (HDL) but not to
lipid-depleted apolipoprotein AI. Several splice variants which
may have diﬀerent functions have been identiﬁed in mammals.
In the current study, we characterized the human splice variant
ABCG1(666), which diﬀers from full-length ABCG1(678) by
absence of an internal segment of 12 amino acids
(VKQTKRLKGLRK). Accordingly spliced ABCG1 transcripts
were detected in macrophages and liver in approximately twofold
higher amounts than the alternatively spliced ABCG1 form
encoding full-length ABCG1. We used transient and stable
expression of ABCG1(666) fusion proteins to characterize glyco-
sylation, subcellular localization, molecular interaction and func-
tions of this ABCG1 variant. It could be demonstrated that
ABCG1(666) is located at the cell surface and has the ability
to form cholesterol transport competent homodimers which aﬀect
cellular cholesterol export in a similar manner as previously
characterized forms of ABCG1. Our results support that
ABCG1(666) may in fact be the most prominent form of func-
tional ABCG1 expressed in the human.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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High-density lipoprotein (HDL) acts in reverse cholesterol
transport as acceptor of excess cholesterol secreted by periphe-
ral cells for transport to the liver and subsequent excretion with
the bile [1]. It is presumed that this role of HDL contributes
importantly to the atheroprotective activity associated with this
lipoprotein class [2,3]. ATP-binding cassette (ABC) transport-
ers are energy-driven molecular pumps that are involved in
transmembrane transport of a variety of substrates, including
lipids, for a review see [4]. It has been shown that several mem-
bers of this gene family are involved in sterol transport across
the plasma membrane, including ABC transporter family
member A1 (ABCA1), ABCG5, ABCG8, and ABC transporter
family member G1 (ABCG1). ABCA1 catalyses the initial step
of HDL-formation, the lipidation of lipid-free apolipoprotein
AI (apoAI), and is essential for HDL-biogenesis. ABCA1 deﬁ-
ciency in Tangier disease results in almost complete lack of
HDL, cholesterol ester accumulation in macrophages and a
high incidence rate of premature atherosclerosis [5–7]. Muta-
tions in the genes encoding ABCG5 and ABCG8 cause sitoster-
olemia [8], a rare recessive disorder associated with plant sterol
and cholesterol hyperabsorption and premature atherosclero-
sis. To date, no human inherited disease has been identiﬁed that
results from ABCG1 deﬁciency, however, ABCG1 has been
studied in vitro in cell cultures and in vivo in mouse models.
It could be demonstrated that overexpression of murine
ABCG1 in cultured cells increased the rate of cellular choles-
terol export to lipoprotein acceptors as well as to cyclodextrin
but not to lipid-depleted apoAI [9,10]. Overexpression of two
human ABCG1 transcripts diﬀering at their N-terminal ends
showed similar results [11]. In addition, that study attributed
a role in cholesterol esteriﬁcation to human ABCG1. Another
study showed that human ABCG1 overexpression increased
cholesterol eﬄux to a wide range of acceptors including
phospholipid liposomes [12]. The strongest support for a role
of ABCG1 in cholesterol transport in vivo came from the char-
acterization of ABCG1 knockout mice. Although the pheno-
type was not associated with altered plasma HDL cholesterol
or low-density lipoprotein (LDL) cholesterol levels, ABCG1
deﬁciency resulted in prominent cholesterol ester, triglyceride,
and phospholipid storage in hepatocytes and macrophages
within multiple tissues when mice were fed a high fat/high cho-
lesterol diet. Transgenic mice overexpressing human ABCG1
showed opposite eﬀects [13].blished by Elsevier B.V. All rights reserved.
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ing frame of 638 amino acids [14]. Subsequently, a number of
other ABCG1 isoforms that are generated by alternative splic-
ing and/or promoter usage were identiﬁed. Full-length ABCG1
consists of 678 amino acids (ABCG1(678)) and is believed to
represent the predominant form of ABCG1 expressed in hu-
man tissues. In this study we characterized a human ABCG1
splice variant, originally identiﬁed by Chen et al. [15], that dif-
fers from full-length ABCG1 by absence of an internal seg-
ment of 12 amino acids due to alternative splicing at the end
of exon 17 [15,16] of the ABCG1 gene. We show that
ABCG1(666) encoding transcripts are app. twofold higher ex-
pressed in human macrophages and the liver compared with
ABCG1(678). In addition, we used transient and stable expres-
sion of ABCG1 fusion proteins to characterize glycosylation,
subcellular localization, molecular interaction and functions
of this ABCG1 variant.2. Materials and methods
2.1. Reagents
Antibodies were purchased from Eurogentec (Herstal, Belgium;
anti-hemagglutinin (HA), HA.11), Roche Diagnostics (Mannheim,
Germany; mouse monoclonal anti-GFP), and Santa Cruz Biotechnol-
ogy (Santa Cruz, CA, USA; rabbit polyclonal HA-probe, and rabbit
polyclonal anti-GFP (SC-805 and SC-8334)). HRP-labelled secondary
antibodies were from BioRad (Hercules, CA, USA). Liver-X-receptor
(LXR) and retinoid-X-receptor (RXR) agonist T0901317 and RO-26-
4456, respectively, were kindly provided by F. Hoﬀmann La-Roche
(Basel, Switzerland), and used at a concentration of 0.1 and 1 lM,
respectively. Glycosidases were obtained from Roche Diagnostics.
An ABCG5-(FLAG)3 plasmid was kindly provided by Dr. Helen
Hobbs, UTSW Dallas, TX, USA [17].2.2. Cells
HeLa cells (DSMZ, Braunschweig, Germany) were maintained in
complete medium (DMEM/10% FCS/100 U/ml penicillin/0.1 mg/ml
streptomycin) in a humidiﬁed incubator at 37 C and 5% CO2. Tet-
Oﬀ-HeLa cells (BD Biosciences Clontech, Heidelberg, FRG) were
maintained in complete medium supplemented with 0.2 mg/ml G418
sulphate in a humidiﬁed incubator at 37 C and 5% CO2. Stably trans-
fected TetOﬀ-HeLa cell lines were maintained in complete medium
supplemented with 0.2 mg/ml G418 sulphate, 0.1 mg/ml hygromycin
B, and 10 ng/ml doxycycline.
2.3. Preparation of lipoproteins
LDL (1.019 < d < 1.063 g/ml), HDL2 (1.063 < d < 1.125 g/ml), and
HDL3 (1.125 < d < 1.210 g/ml) were isolated from plasma of normo-
lipidemic volunteers by sequential ultracentrifugation [18] and were
dialyzed against PBS. Lipid-free apoAI was puriﬁed from freshly iso-
lated HDL3 according to established procedures [19].
2.4. PCR ampliﬁcation of ABCG1 splice product fragments
Human liver or monocyte-derived macrophage cDNA was ampliﬁed
in a PCR reaction using HotstarTaq (Qiagen) and the following two
primers: 5 0-CTGAACTGCCCAACCTACCACAAC-3 0; 5 0-ATGA-
TGCTGAGGAAGGTCCTCTTG-3 0. 10% DMSO was added and 30
cycles were performed using the following thermocycler settings: 30 s
at 94 C, 40 s at 57 C, 30 s at 72 C. The PCR reaction was separated
on a 2.5% agarose TAE gel and bands were visualized using ethidium
bromide.
2.5. Cloning
Coding sequence of ABCG1(678) (NM_004915.2; bp 31–2055)
ABCG1(666) (NM_016818.1; bp 31–2019), ABCG2 (NM_004827.1;
bp 205–2172), ABCG4 (NM_022169.3; bp 337–2277), ABCG5
(NM_022436.2; bp 141–2096), and ABCG8 (NM_022437.2; bp 91–2112) were ampliﬁed from human cDNAs of diﬀerent tissues with
ﬂanking XhoI at the 5 0-end and XbaI (ABCG1, ABCG2, ABCG4),
KpnI (ABCG5), or BamHI (ABCG8) restriction sites at the 3 0-end
and inserted in frame with enhanced green ﬂuorescent protein (EGFP)
into pEGFP-C1 vector (Clontech) or into a modiﬁed pEGFP-C1 vec-
tor where the GFP had been replaced by a triple repeat of the inﬂuenza
virus hemagglutinin epitope tag (HA: YPYDVPDYA). Since cloning
of correctly spliced ABCG5 failed repeatedly, ABCG5 was ampliﬁed
using a plasmid coding for ABCG5-(FLAG)3 as template [17]. Point
mutations were introduced using QuikChange Kit according to the
manufacturer’s guidelines (Stratagene). All ampliﬁed sequences were
veriﬁed by DNA sequencing using the ABI PRISM BigDye Termi-
nators v3.1 Cycle Sequencing Kit (Applied Biosystems). Sequencing
reactions were separated on an ABI-PRISM 3700 DNA Analyzer
(Applied Biosystems).2.6. Expression of ABC transporters in HeLa cells
For transient expression experiments 1.6 · 106 trypsinized HeLa
cells in 0.4 ml DMEM were transfected with 10 lg plasmid DNA using
an electroporator equipped with a capacitance extender (GenePulser
II, BioRad) at 975lF and 230 V. Cells were seeded on six 12 mm diam-
eter cover slides in 24-well dishes and ﬁxed with 4% PFA in PBS 48 h
post transfection. Samples were counterstained with wheat germ agglu-
tinin-Alexa 594 (Molecular Probes, Leiden, The Netherlands). Cover-
slips were mounted on glass slides using Mowiol supplemented with
N-propyl-gallate as anti-fading agent and were viewed with a Zeiss
LSM510 confocal microscope. Images were processed using Adobe
Photoshop 7.0. Stable transfections of TetOﬀ-HeLa cells were per-
formed as described above with 4 · 106 cells in 0.4 ml DMEM and
40 lg expression plasmid plus 2 lg pTK-Hyg (Clontech) selection plas-
mid. Cells were seeded in 10 tissue culture dishes with 15 cm diameter.
For selection 0.2 mg/ml G418 (Gibco BRL), 0.2 mg/ml hygromycin B
(Carl Roth, Karlsruhe, FRG), and 1 lg/ml doxycycline (Sigma) was
added to complete medium. Medium was changed every 3–4 days,
doxycycline was added every two days. Single clones were selected
after 2–3 weeks using 8 mm cloning cylinders (Bellco Glass, Vineland,
NJ), and screened by indirect immunoﬂuorescence microscopy and
Western blot analysis using the rabbit polyclonal anti-GFP or mouse
monoclonal anti-HA.11 antibody, respectively. When plating the cells
for experiments hygromycin B and G418 was omitted and doxycycline
was used as indicated.2.7. Immune precipitations
Cells were washed with PBS and washed oﬀ the plate in ice cold lysis
buﬀer (50 mM Tris, pH 7.4, 150 mM NaCl, 1% (v/v) Triton-X 100)
supplemented with protease inhibitor cocktail (Roche Diagnostics)
plus 1 mM DTT and were lysed for 2 h on a rotating wheel at 4 C.
Supernatants were harvested by centrifugation and were precleared
for 1 h using protein G-Sepharose 4B beads (Amersham Pharmacia
Biotech, Freiburg, Germany). Antigen was immune precipitated by
incubating the supernatants with mouse monoclonal anti-GFP IgGs
prebound to protein G-Sepharose 4B beads for 2 h. Beads were
harvested and washed ﬁve times with lysis buﬀer and processed for
Western blot analysis.2.8. Surface biotinylation
All steps were performed at 4 C. One million cells in a 35 mm
dish were washed twice with cold PBS and were incubated with
PBS supplemented with 30 lg sulfo-NHS-biotin for 30 min. Cells
were washed twice with PBS and unreacted biotin was quenched
by 30 min incubation with Tris-buﬀered saline. Cells were washed
oﬀ the plate in ice cold lysis buﬀer (50 mM Tris, pH 7.4, 300 mM
NaCl, 0.5% (w/v) sodium deoxycholate, and 2% (v/v) Triton-X
100) supplemented with protease inhibitor cocktail (Roche Diagnos-
tics) plus 1 mM DTT and were lysed for 2 h on a rotating wheel at
4 C. Supernatants were harvested by centrifugation and were pre-
cleared for 1 h using protein G-Sepharose 4B beads (Amersham
Pharmacia Biotech). Antigen was immune precipitated by incubating
the supernatants with mouse monoclonal anti-HA IgGs prebound to
protein G-Sepharose 4B beads for 2 h. Beads were harvested and
washed ﬁve times with lysis buﬀer and processed for Western blot
analysis using an goat anti-biotin antibody followed by donkey
anti-goat HRP.
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Immune precipitates from transiently transfected HeLa cells lysed
with lysis buﬀer (50 mM Tris, pH 7.4, 300 mM NaCl, 0.5% (w/v) so-
dium deoxycholate, and 2% (v/v) Triton-X 100) were eluted from the
protein G-beads with 0.1% (w/v) SDS, 1 mM 2-mercapto-ethanol,
50 mM Tris, pH 7.4 and aliquots were digested with diﬀerent glyco-
sidases in their respective digestion buﬀers according to the manu-
facturer’s guideline (Roche Diagnostics). Before digestion Triton-X
100 was added to a 20-fold molar excess over SDS, 2-mercapto-eth-
anol was diluted to less than 0.1 mM. Reactions were incubated over
night at 37 C. Samples were precipitated with TCA, pellets were
washed with acetone and dissolved in Laemmli sample buﬀer supple-
mented with 5% (v/v) 2-mercapto-ethanol (SDS-sample buﬀer) and
processed for Western blot analysis. Anti-HA antibody was used
for detection.2.10. Western blot analysis
Samples were lysed in SDS-sample buﬀer and separated on 10%
SDS–PAGE gels [20]. Protein was transferred onto Protran nitrocellu-
lose ﬁlters, 0.2 lm pore size (Schleicher & Schuell, Dassel, Germany).
For detection with HRP-labeled secondary antibody 2% (w/v) dry
skim milk/PBS/0.1% (v/v) Tween 20 was used for blocking the ﬁlter
and for antibody incubations, for detection of biotinylated proteins
PBS/1 M NaCl/0.1% (v/v) Tween 20 was used for blocking and anti-
body incubations. For detection horseradish peroxidase (HRP)-labeled
secondary antibody (BioRad), ECL system and Hyperﬁlm ECL was
used (Amersham Pharmacia Biotech).2.11. Cholesterol eﬄux measurement
Cholesterol eﬄux measurements were performed as previously de-
scribed [21]. Cells were grown in a 24-well tissue culture plate. Conﬂu-
ent cells were labeled overnight with 0.5 ml/well of DMEM/0.2% (w/v)
bovine serum albumin (BSA)/with or without agonists (1 lM
T0901317 and 100 nM RO-26-4456) and 0.5 lCi [3H]cholesterol
(NEN-DuPont, Dreieich, Germany) per well. Cells were washed with
warm DMEM/0.5% (w/v) BSA ﬁve times for 10 min each and with
DMEM once. 0.3 ml eﬄux medium consisting of DMEM/0.2% (w/v)
BSA with or without supplements (1 lM T0901317/100 nM RO-26-
4456 with or without 20 lg/ml apoAI, 25 lg/ml HDL3, HDL2, or
LDL) for several hours, as indicated. Medium was harvested, cells
were removed by centrifugation and radioactivity of a 0.25 ml aliquot
of the supernatant fraction was determined. Cells were lysed by adding
0.25 ml 1 M NaOH/0.15 M NaCl to each well of the plate. AfterEndoH
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Fig. 1. Human ABCG1(666) internal short splice variant is more abundant th
macrophage (lane 1) and liver (lane 2) cDNA was PCR-ampliﬁed with a prim
materials and methods. ABCG1 transcript lacking the internal dodecapeptid
was ampliﬁed as a 313 bp fragment. (B) HeLa cells were either mock-transfec
ABC transporters of the G subfamily for 48 h. Internally spliced short v
precipitation and digested with diﬀerent glycosidases, as indicated in panel B
glycosidase). Samples were separated by SDS–PAGE and proteins were visua
a rabbit polyclonal anti-HA antibody. The band at 55 kDa is IgG heavy cha
the ABC-transporters are indicated with ABCGx at the left.10 min lysates and pelleted cells were combined in scintillation vials,
plates were washed again with 0.25 ml of 1 M NaOH/0.15 M NaCl
and radioactivity of the samples was determined. The fractional cho-
lesterol eﬄux was determined as described [21].3. Results
The relative level of expression of alternatively spliced
ABCG1 transcripts was determined by RT-PCR followed by
agarose gel electrophoresis. As shown in Fig. 1A, RT-PCR
with oligonucleotide primers ﬂanking the 36 bp insertion/dele-
tion resulted in two fragments of 277 (corresponding to
ABCG1(666)) and 313 bp (corresponding to ABCG1(678)).
Compared to ABCG1(678), ABCG1(666) encoding transcripts
were more than twice as abundantly expressed in human
monocyte-derived macrophages and liver. This observation
was conﬁrmed further by the result that during cloning of
the 2 kb coding sequence of the transporter from macro-
phage cDNA ABCG1(666) was obtained twice as often than
ABCG1(678).
As NetNGlyc 1.0 server (http://www.cbs.dtu.dk/services/
NetNGlyc/) predicted a glycosylation site in ABCG1(666)
and ABCG1(678), we tested whether this site is functional in
ABCG1(666). We expressed HA-tagged ABC transporters of
the G-subfamily and digested anti-HA immune precipitates
with diﬀerent glycosidases. Fig. 1B shows that ABCG1(666)
and ABCG4 are no glycoproteins. Neither endoglycosidase
H (endoH), N-glycosidase F (PNGaseF), nor O-glycosidase
(endoO) treatment shifted the molecular weight of ABCG1
or ABCG4. As positive controls, the weight of the highly gly-
cosylated plasma membrane form of ABCG2 was lowered
by PNGaseF- but not by endoH- or endoO-treatment and
the weight of endoplasmic reticulum-retained ABCG5
was decreased by endoH- and PNGaseF- but not by endoO-
treatment, as expected [17,22]. Since ABCG1(666) and
ABCG4 are no glycoproteins, their intracellular transport-
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an ABCG1(678) and is no glycoprotein. (A) Human monocyte-derived
er pair adjacent to the internal alternative splicing site, as indicated in
e yielded a PCR product of 277 bp, whereas the alternative transcript
ted or transfected with a plasmid coding for HA-tagged versions of the
ersion, ABCG1(666), was used. Proteins were puriﬁed by immune
(EndoH, endoglycosidase H; PNGaseF, N-glycosidase F; EndoO, O-
lized by Western blot analysis, as stated in materials and methods using
in (IgG-HC) and served as a loading control. Signals corresponding to
Fig. 2. ABCG1(666) colocalizes with wheat germ agglutinin (WGA)
and can be biotinylated at the cell surface. (A) HeLa cells were
transfected with constructs coding for EGFP-ABCG1(666) or EGFP-
ABCG2 fusion proteins for 48 h. Cells were ﬁxed with PFA and
counterstained with WGA-Alexa 594. Confocal sections show
colocalization of EGFP-ABCG1 as well as ABCG2 with WGA at
the cell surface. Green signals show EGFP epiﬂuorescence, red signals
show WGA-Alexa 594, colocalization is indicated by yellow color in
the merged image. Scale bars represent 25 lm. (B) HeLa cells were
transfected with constructs coding for (HA)3-ABCG1(666) or (HA)3-
ABCG5 fusion proteins for 48 h. At 4 C living cells were surface
biotinylated and after immune precipitation using the HA.11 antibody
samples were separated by SDS–PAGE. An anti-biotin antibody
followed by donkey anti-goat IgG-HRP detected biotin. ABC trans-
porters in immune precipitates were detected using HA-probe followed
by goat anti rabbit IgG-HRP. ABCG1 could be surface biotinylated,
whereas ABCG5 could not.
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post-translational modiﬁed intermediates.
In order to study intracellular traﬃcking and localization of
ABCG1(666), we expressed ABCG1(666) and ABCG2 con-
taining an HA epitope-tag or EGFP at their N-termini. As
shown in Fig. 2A, the EGFP-ABCG1(666) and EGFP-
ABCG2 fusion proteins were both detected at the plasma
membrane. In addition, we could demonstrate that EGFP-
ABCG1(666) and EGFP-ABCG2 both colocalized with
Alexa594-labeled wheat germ agglutinin, a marker for the
plasma membrane (Fig. 2A). To rule out that ABCG1(666)
was in close proximity rather than directly at the plasma mem-
brane, we also performed surface biotinylation of living cells
expressing (HA)3-ABCG1 or (HA)3-ABCG5 at 4 C
(Fig. 2B). (HA)3-ABCG1 was biotinylated, whereas, as a con-
trol, (HA)3-ABCG5, which is retained misfolded in internal
endoplasmic reticulum membranes without coexpression of
its partner ABCG8 [23], was not. Taken together, these results
indicate that internally spliced ABCG1(666) is correctly tar-
geted towards the plasma membrane.
Next, we analyzed the function of ABCG1(666) by testing
cellular cholesterol eﬄux using TetOﬀ HeLa cell lines stably
expressing the transporter. We selected for doxycycline regu-
latable cell lines expressing ABCG1(666) homogenously as
shown in Fig. 3. Fig. 4 shows the doxycycline dose response
curve obtained for cholesterol eﬄux in the absence or presence
of HDL3 in the medium. Doxycycline concentrations of over
100 pg/ml had no further decreasing eﬀect on cholesterol ex-
port. Already at a doxycycline concentration of 10 pg/ml satu-
ration of cholesterol export to BSA was observed, whereas
HDL3 export reached 30% of the maximal eﬀect. This diﬀer-
ence most likely reﬂects the much lower cholesterol binding
capacity of BSA than that of HDL3. Cholesterol export de-
pended on ABCG1 expression since ABCG2 expression was
ineﬀective (Fig. 4). Overexpression of (HA)3-ABCG1(666) in
TetOﬀ HeLa cell lines mediated export of cholesterol to a vari-
ety of extracellular acceptors in an acceptor independent man-
ner (Fig. 5). Both, lipoprotein particles as well as serum
albumin take up cholesterol twice as eﬃciently from wt
ABCG1 expressing cells as compared to the same cell line
where ABCG1 expression had been turned oﬀ by application
of doxycycline, the parental TetOﬀ HeLa cells or a cell line
expressing inactive mutant ABCG1(666; K124M). ApoAI-
mediated cholesterol eﬄux was essentially absent in the wt
ABCG1(666) expressing cells. Phosphatidylcholine eﬄux was
not signiﬁcantly aﬀected by overexpression of wt ABCG1(666)
(not shown).
Since ABCG1(666) was detected at the cell surface and was
functional, we assumed that the transporter was part of a full
transporter, in analogy to results obtained for the hetero-
meric ABCG5 and ABCG8 complex and the homomeric
ABCG2 [17,24,25]. Therefore, we performed non-reducing
SDS–PAGE and subsequent Western blot analysis of samples
containing wt or mutant (HA)3-ABCG1(666) or (HA)3-
ABCG2. As shown in Fig. 6, in contrast to samples contain-
ing ABCG2, the ABCG1-containing ones showed presence of
monomeric transporter, thus indicating that ABCG1 forms a
full transporter without bridging through intermolecular
disulﬁde bonds. Interestingly, in case of wt ABCG1 express-
ing samples a faint band at the expected dimeric weight of
approximately 130 kDa was visible (indicated with an aster-
isk), even without chemical cross-linking, which was missingin the case of inactive ABCG1(666;K124M). This supported
that the band of the dimeric size was not an artifact of over-
Fig. 3. ABCG1(666; K124M) mutant localizes at the cell surface and
expression can be regulated by doxycycline. TetOﬀ HeLa cells were
stable transfected with plasmids coding for wt (HA)3-ABCG1(666),
mutant (HA)3-ABCG1(666; K124M) or (HA)3-ABCG2, respectively.
Positive clones were selected and analyzed by indirect immunoﬂuo-
rescence microscopy using HA.11 antibody followed by an Alexa
488-coupled goat anti-mouse IgG (A–D) or by Western blot analysis
using HA.11 antibody followed by an HRP-coupled goat anti-mouse
IgG (E). (A) Lanes 3 and 4: (HA)3-ABCG1(666) clone 94. (B) Lanes 5
and 6: (HA)3-ABCG1(666; K124M) clone 47. (C) Lanes 7 and 8:
(HA)3-ABCG2 clone 63. (D) Lanes 1 and 2: TetOﬀ HeLa cells.
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doxycycline, as described in Section 2.
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changes of the active transporter during its ATPase cycle that
may expose internal cysteins. Application of LXR and RXR
agonists did not inﬂuence the intensity of the dimeric band
but seemed to have a protective eﬀect on ABCG1 protein
stability, because ABCG1 degradation products occurred less
prominently when agonists were applied. Coexpression of the
two ABCG1 splice variants ABCG1(666) and ABCG1(678)
aﬀected the signal intensity of the dimeric complex only mar-
ginally (Fig. 6B). The only diﬀerence was absence of the
55 kDa degradation product and appearance of a band at
slightly higher molecular weight. This result may indicate that
the two ABCG1 variants may in fact be able to form mixed
complexes, which diﬀer from homodimers by their accessibil-
ity to proteases.
Since these results indicated that the ABCG1 complex could
not be easily analyzed by non-reducing gel electrophoresis we
carried out analysis of immune precipitates of coexpressed
ABC transporters of the G-family. We coexpressed all mem-
bers of the G-family of ABC transporters with each other as
HA- and GFP-tagged versions in various combinations and
probed the anti-GFP immune precipitate with anti-GFP and
anti-HA antibodies, as shown in Fig. 7. If interaction occurred,
a signal should be present in the lower panel probed for hem-
agglutinin. In the case of EGFP-ABCG1 (panel A) predomi-
nantly interaction with HA-ABCG1 and to a small extent
with HA-ABCG4 could be detected. In compliance with previ-
ous observations, ABCG2 formed homodimers (panel B),
ABCG5 (panel D) and ABCG8 (panel E) formed heterodimers
with each other [22,23]. ABCG4 formed homodimers and to a
small extent heterodimers with ABCG1 (panel C).4. Discussion
In the present study we characterized expression, molecular
properties, localization and function of a previously identiﬁed
human ABCG1 transcript which, due to alternative splicing,
Fig. 6. Disulﬁde bonds do not link ABCG1(666) full transporter. (A) Samples from TetOﬀ HeLa cell lines expressing wt or mutant (K124M) (HA)3-
ABCG transporter, as indicated, were subjected to reducing (right panel) or non-reducing (left panel) SDS–PAGE and subsequent Western blot
analysis with HA.11 antibody followed by goat anti-mouse HRP-labeled secondary antibody. An asterisk indicates a putative dimeric ABCG1
complex. G1-94, (HA)3-ABCG1(666) clone 94; G1KM-47, (HA)3-ABCG1(666, K124M) clone 47; G2-63, (HA)3-ABCG2 clone 63. (B) Samples from
TetOﬀ-HeLa cells containing transiently expressed (HA)3-ABCG1(666), indicated with S, or (HA)3-ABCG1(678), indicated with L, or a combination
of both were processed as above.
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sence of an internal segment of 12 amino acids (Fig. 8). The
studied human cell-types liver and monocyte-derived macro-
phages, that were previously shown to contain large amounts
of ABCG1 [13], provided considerably more intense signals
corresponding to transcripts encoding the ABCG1(666) form
with the 12 aa deletion than to full length ABCG1(678)
(Fig. 1A). The expressed sequence tag database at the NCBI
conﬁrms this observation with a ratio of ﬁve long (DA278-
234.1, AA860987.1, DA255931.1, BQ640204.1, AW467144.1)
versus 10 short internally spliced transcripts (DA382048.1,
DA464214.1, BX419732.2, CD628158.1, CD628157.1, CD62-
8156.1, BF871693.1, BX427799.2, CD628159.1, BG74717-
1.1). The long transcript may occur in humans only, as the
non-redundant database (NR) at the NCBI contains ABCG1
sequences in other species spliced comparable to the short
ABCG1(666) variant only (Fig. 8A). In addition, the human
ABCG4 transcript, the closest homolog of ABCG1 [26], has
a similar sequence gap at the same position (Fig. 8A). This sug-
gests that ABCG1(666) may in fact be the most prominent
form of ABCG1 expressed in humans.
Alternative splicing represents an attractive mechanism for
expression of functionally diverse products from a single
gene. A potentially regulatory role mediated by gene silenc-
ing has for example been attributed to a non-functional form
of P-glycoprotein resulting from alternative splicing upon
ABCB1 transcription [27]. In Drosophila melanogaster, alter-
native internal splicing at positions between exon 4 and exon
8 of dMRP has been reported to result in as many as 14
diﬀerent proteins [28]. Although the precise role of this var-
iation, which occurs within the second and third membrane-
spanning domain of the transporter, is currently unclear, it
seems likely that it contributes to the broad substrate speci-ﬁcity required for dMRP function. Alternative internal splic-
ing of the human ABCB4 (MDR3) cDNA was reported as
well, however without eﬀect on the protein sequence [29].
In the case of SUR2 (ABCC9), two functional variants have
been described, which diﬀer with respect to the ﬁrst nucleo-
tide binding fold of the transporter based on absence or
presence of exon 17 coding information in the spliced tran-
scripts [30].
Since our results show very clearly that ABCG1(666) en-
codes a functional ABC transporter, a regulatory role as has
been proposed in case of the alternatively spliced form of P-
glycoprotein may be excluded for ABCG1(666). Our data
rather support that the 12 aa deletion does not interfere with
the basic cholesterol export function of the transporter.
According to the multiple sequence alignments of homologous
and orthologous peptide sequences similar to human ABCG1
at the position ﬂanking the insertion/deletion shown in
Fig. 8A, the insertion may occur speciﬁcally in humans, since
the non-redundant database (NR) at the NCBI contains only
ABCG1 sequences of mouse, rat, dog, cattle and zebraﬁsh
which are spliced according to the short ABCG1(666) variant.
In addition, the human ABCG4 transcript, the closest homo-
log of ABCG1 [26], has a similar sequence gap at the same
position (Fig. 8A). Further analysis with the DISEMBL
program (http://dis.embl.de/) supports that this stretch of
sequence and the adjacent region has a highly unordered struc-
ture (indicated as hotloop and disordered) and, therefore, may
act as a ﬂexible linker connecting the ATPase and transmem-
brane spanning domain of the transporter (Figs. 8A and B).
Based on these considerations, we presume that ABCG1(666)
represents the evolutionary conserved prototype transporter
whereas ABCG1(678) may be a primate-speciﬁc variant that
arose later in evolution.
Fig. 7. ABCG1 interacts with itself. HeLa cells were cotransfected with a combination of one HA-tagged and one GFP-tagged ABC transporter of
the G-subfamily or only one of them. After lysis, GFP-tagged ABC transporters were immune precipitated and HA- as well as GFP-tagged proteins
were detected by Western blot analysis. Interaction of ABC transporters with each other is evident, if protein in the anti-GFP precipitate can be
detected using the anti-HA antibody. The following fusion proteins were used as baits: panel A: EGFP-ABCG1(666); panel B: EGFP-ABCG2; panel
C: EGFP-ABCG4; panel D: EGFP-ABCG5; panel E: EGFP-ABCG8.
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sic properties and activities of ABCG1(666) are in fact very
similar as compared with previously characterized ABCG1
variants containing the 12 aa insertion, our data also point
to a number of potential diﬀerences that may exist between
the ABCG1 isoforms. In our study, ABCG1(666) expression
was not associated with stimulation of cholesterol esteriﬁca-
tion as was observed by Vaughan and Oram who expressed
two ABCG1 variants containing the 12 aa insertion in BHK
cells [11]. Gelissen et al. expressed ABCG1(674), a variant also
containing the 12 aa insertion, in CHO cells [12]. They found
the majority of the expressed protein intracellularly associated
with the endoplasmic reticulum and not, as in our case, within
the plasma membrane. These diﬀerences may relate to subtle
distinctions with respect to the precise intracellular traﬃcking
routes and/or the eﬃcacy by which the transporters are direc-
ted towards the plasma membrane. On the other hand, there
clearly are a number of experimental diﬀerences between the
studies. Vaughan and Oram used an N-terminal tag in their
experiments similar as we did, whereas Gelissen et al. tagged
the expressed transporter at its C-terminus [11,12]. It is knownfor other ABC transporters of the G-family that the location of
the tag inﬂuences traﬃcking and is important for correct tar-
geting towards the plasma membrane [23,31,32]. This is pre-
sumably due to the fact that all G-family ABC transporters
lack a signal peptide but have a short carboxy-terminal tail
after the last transmembrane domain which acts as targeting
signal for membrane insertion as is the case for type-II trans-
membrane spanning proteins. Blocking this signal may result
in ineﬃcient incorporation of the transporter into and target-
ing towards the target membranes.
Our results show that ABCG1(666) acts as homodimer.
Homodimerization of ABCG1 was earlier concluded also by
others, either by indirect means like interference of an ER-re-
tained misfolded ABCG1-mutant with cholesterol export [11],
or simply by the fact that overexpression of ABCG1 enhanced
cholesterol export, although that observation did not rule out
that ABCG1 had been complexed with another half trans-
porter that was present in larger quantities than endogenous
ABCG1 [9–12,33]. Recently, homodimerization was shown
by coimmuneprecipitation and Western blot detection of coex-
pressed variants harboring two diﬀerent epitope tags [12].
1_HSG1A    1 SDHKRDLGGDAEVNPFLWHRPSEE------------DSSSMEGCHSFSASCLTQFCILFKRTFL
2_HSG1B    1 SDHKRDLGGDAEVNPFLWHRPSEEVKQTKRLKGLRKDSSSMEGCHSFSASCLTQFCILFKRTFL
3_MMG1_    1 ADYKRDLGGDTDVNPFLWHRPAEE------------DSASMEGCHSFSASCLTQFCILFKRTFL
4_RNG1_    1 SDYKRELGGDGDVNPFLWHRPAEE------------DSASMEGCHSFSASCLTQFCILFKRTFL
6_CFG1_    1 SEHRREPGGDAEVNPFLWHRPSEE------------DSTSMEGCHSFSASCLTQFCILFKRTFL
5_BTG1_    1 SDCRREPGGDAEVNPFIWHRPSEE------------DSTSMEGCHSFSASCLTQFCILFKRTFL
7_DRG1_    1 KDYKTEMNGNGVHNPFLWHRPSDE------------DSSSSEGCHSFSASCLTQFCILFKRTFL
8_HSG4_    1 MAEKKSSPEKNEVPAPCPPCPPEV------------DPIES---HTFATSTLTQFCILFKRTFL
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Fig. 8. Insertion of dodecapeptide into ABCG1(666) within a ﬂexible linker region. (A) This multiple sequence alignment shows diﬀerences between
homologous and orthologous peptide sequences similar to human ABCG1 at the position ﬂanking the alternative splice site at the end of exon 17
[15,16]. Identical amino acids are indicated with black, homologous amino acids with gray boxes. Within this stretch of sequence a region of intrinsic
protein disorder is present, as indicated with boxes labeled as ‘‘hotloop’’ or ‘‘disordered’’ according to DisEMBL program within the Simple
Modular Architecture Research Tool (SMART) at the EMBL homepage (http://www.smart.embl-heidelberg.de) [34,35]. Following nucleotide
database accessions were used for the alignment: HSG1A: H. sapiens ABCG1(666) NM_016818.2; HSG1B: H. sapiens ABCG1(678) NM_004915.3;
MMG1: M. musculus ABCG1 NM_009593.1; RNG1: R. norvegicus ABCG1 NM_053502.1; BTG1: B. taurus ABCG1 XM_587930.2; CFG1: C.
familiaris ABCG1 XM_544902.2; DRG1: D. Rerio ABCG1 XM_679931.1; HSG4: H. sapiens ABCG4 NM_022169.3. (B) Shows a schematic
topology model of ABCG1. The predicted, potential N-linked glycosylation site (NGS) in human ABCG1 protein is indicated (*). The mutated site
in the Walker-A motif of the transporter, used for generating ABCG1(666; K124M) mutant, is indicated as well (#). The 12 amino acid segment
present in ABCG1(678) is indicated.
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complexes with other members of the G-family of ABC-trans-
porters, like was shown for the heteromeric ABCG5/ABCG8
complex [17,23]. Another study led to the assumption that
ABCG4 and ABCG1 may be able to form a heterodimer, since
human ABCG1 ATPase activity in insect cells could be inhib-
ited by expression of human ATPase-deﬁcient ABCG4 [33].
Our results conﬁrm this observation in a more direct manner
and exclude that ABCG1 forms complexes with any other
ABC-transporter of the G-family.
Our results show that ABCG1(666)-mediated cholesterol ex-
port is rather promiscuous with respect to the cholesterol
acceptor, since we observed a doubling of cholesterol export
to HDL2, HDL3 and LDL. However, as has been shown byothers for ABCG1(678) [10–12], ABCG1(666) mediated al-
most no cholesterol eﬄux if apoAI was used as the acceptor.
This diﬀerentiates all studied forms of ABCG1 from ABCA1
which has clear acceptor speciﬁcity for lipid-free apolipopro-
teins and not for HDL.
In summary, our data support that ABCG1(666) is a
functional ABCG1 variant which may in fact be the most
prominent form of functional ABCG1 expressed in the
human.
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